Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transcatheter Tricuspid Valve Replacement Using the Medtronic Intrepid™ TTVR System in Patients With Severe Symptomatic Tricuspid Regurgitation - PATHFINDER

NCT07321899 is registered in ClinicalTrials.gov with Medtronic Cardiovascular as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07321899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transcatheter Tricuspid Valve Replacement Using the Medtronic Intrepid™ TTVR System in Patients With Severe Symptomatic Tricuspid Regurgitation - PATHFINDER
Lead sponsor
Medtronic Cardiovascular
Phase
Not applicable
Overall status
Recruiting
Start date
September 11, 2026
Completion date
April 30, 2041
Enrollment
1,186 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

severe tricuspid regurgitation